Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:GIC
NYSE:GICTrade Distributors

A Look At Global Industrial (GIC) Valuation After Recent Share Price Momentum Cooldown

Global Industrial (GIC) has been drawing investor attention after recent share price moves, with the stock down over the past month but still positive over the past 3 months and year to date. See our latest analysis for Global Industrial. That recent 6.1% 30 day share price decline comes after a stronger run. A 2.9% 90 day share price return and a 44.7% 1 year total shareholder return suggest momentum has cooled, but longer term holders are still ahead. If this move has you reassessing...
ASX:LYC
ASX:LYCMetals and Mining

A Look At Lynas Rare Earths (ASX:LYC) Valuation After Long Term JARE Deal And Malaysian Licence Renewal

Lynas Rare Earths (ASX:LYC) is back on investor radars after extending its supply agreement with Japan Australia Rare Earths to 2038, adding price floors, upside sharing, and renewed Malaysian operating certainty. See our latest analysis for Lynas Rare Earths. The extended JARE deal and Malaysian licence renewal have arrived alongside strong momentum, with a 30 day share price return of 39.83% and a year to date share price return of 73.24%. The 1 year total shareholder return of 191.60% and...
NasdaqGM:HPK
NasdaqGM:HPKOil and Gas

HighPeak Energy (HPK) Margin Compression And One Off Loss Test Bullish Thesis

HighPeak Energy (HPK) closed out FY 2025 with Q4 revenue of US$216.6 million and a basic EPS loss of US$0.17, as full year trailing 12 month EPS came in at US$0.15 on revenue of US$863.4 million. Over recent quarters the company has seen quarterly revenue move between US$188.9 million and US$257.4 million, with basic EPS ranging from a profit of US$0.26 per share in Q1 2025 to losses in Q3 and Q4. This set up a year where margins were thin and earnings quality is a key focus for...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

SoFi Technologies (SOFI) Is Down 8.1% After Mastercard Expands SoFiUSD Stablecoin Settlement Partnership

In early March 2026, SoFi Technologies and Mastercard announced an expanded partnership allowing SoFiUSD, SoFi’s fully reserved U.S. dollar stablecoin, to be used as a settlement option across Mastercard’s global payments network, with SoFi Bank expected to settle its own card transactions in SoFiUSD and Galileo offering this option to clients. This move positions SoFi as the first U.S. nationally chartered and insured deposit bank to issue a stablecoin on a public, permissionless...
SWX:BKW
SWX:BKWElectric Utilities

BKW (SWX:BKW) Net Margin Drop To 7.9% Tests Bullish Earnings Narratives

BKW (SWX:BKW) has put out its FY 2025 numbers with first half revenue of CHF 2.1b and basic EPS of CHF 3.54. This sets the tone for a year in which trailing twelve month revenue sits at CHF 4.5b and EPS at CHF 6.77. Over the last few reporting periods, the company has seen revenue move from CHF 2.2b and EPS of CHF 6.62 in 1H 2024 to CHF 2.4b and EPS of CHF 5.18 in 2H 2024, before landing at the latest 1H 2025 figures. This leaves investors focused on how the compression in net profit margins...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio’s (IBRX) Bladder Cancer sBLA Resubmission Tests The Depth Of Its Immuno‑Oncology Strategy

ImmunityBio recently reported that the FDA has acknowledged receipt of its resubmitted supplemental Biologics License Application for ANKTIVA plus BCG to treat BCG‑unresponsive non‑muscle invasive bladder cancer with papillary tumors, supported by updated long‑term efficacy and safety data from the QUILT 3.032 trial. This filing is backed by what is described as the longest follow‑up data set for high‑risk papillary‑only NMIBC, highlighting durable bladder‑sparing outcomes that seek to...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

Is It Time To Reconsider BioNTech (BNTX) After Its Recent Share Price Weakness?

If you are wondering whether BioNTech's current share price lines up with its long term potential, starting with a clear look at valuation can help you frame that question more calmly. BioNTech's shares recently closed at US$90.10, with returns of 11.6% decline over the past week, 17.3% decline over the last month, and 6.8% decline year to date, alongside 7.6% decline over 1 year, 31.7% decline over 3 years, and 12.2% decline over 5 years, which hints that the market's view on risk and...
NasdaqGS:IDXX
NasdaqGS:IDXXMedical Equipment

A Look At IDEXX Laboratories (IDXX) Valuation After Recent Share Price Weakness

IDEXX Laboratories (IDXX) has drawn investor attention after recent share price weakness, with the stock down around 5% over the past week and roughly 19% over the past 3 months. See our latest analysis for IDEXX Laboratories. That recent 4.9% one day share price decline, on top of a 7.7% 7 day and 11.7% 30 day share price pullback, sits in contrast to IDEXX Laboratories' 40.6% 1 year total shareholder return. This suggests momentum has cooled after a strong run. If this shift in sentiment...
NYSE:CNH
NYSE:CNHMachinery

Assessing CNH Industrial (CNH) Valuation After Recent Share Price Pullback

Event context and recent share performance CNH Industrial (CNH) shares have been under pressure recently, with a 1 day return of roughly a 2% decline and a 7 day return of about a 6% decline, drawing attention to the stock’s current pricing. Over the past month the stock shows around a 13% decline, while the past 3 months reflect roughly a 9% total return, giving investors mixed short term signals around a business that reports US$18,095m in revenue and US$510m in net income. See our latest...
NYSE:AME
NYSE:AMEElectrical

How AMETEK’s Earnings Beat, Guidance Hike, and Bigger Dividend Will Impact AMETEK (AME) Investors

In recent weeks, AMETEK reported quarterly results that exceeded analyst expectations, raised its full-year guidance, and approved a 10% increase in its quarterly cash dividend, while continuing to invest heavily in growth projects. These developments, coupled with long-term institutional backing from investors like GAMCO and increased interest from hedge funds, highlight how AMETEK’s earnings momentum and capital allocation policies are shaping perceptions of its quality and...
ENXTAM:AALB
ENXTAM:AALBMachinery

Aalberts Reshapes Portfolio With BROEN Sale And €75m Buyback Plan

Aalberts has completed the divestment of BROEN A/S, advancing its ‘thrive 2030’ repositioning plan. The company is running a significant share buyback programme alongside the transaction. ENXTAM:AALB last closed at €32.78. For you as an ENXTAM:AALB watcher, these moves relate directly to how Aalberts is reshaping its portfolio and capital structure. The share price stands at €32.78, with a 14.9% gain year to date and a 3.5% return over 1 year, while 3 year and 5 year returns show declines...
NasdaqCM:MNTK
NasdaqCM:MNTKRenewable Energy

Montauk Renewables (MNTK) Margin Compression To 1% Tests Bullish Growth Narratives

Montauk Renewables (MNTK) closed out FY 2025 with Q4 revenue of US$43.4 million and basic EPS of US$0.02 on net income of US$2.5 million, setting the tone for a year where reported earnings and margins were under close watch. The company has seen quarterly revenue move from US$27.7 million and basic EPS of US$0.06 in Q4 2024 to a mix of losses and profits through 2025, including Q2 revenue of US$45.1 million with a loss of US$5.5 million and basic EPS of US$0.04, before landing on US$45.3...
NasdaqGS:LASR
NasdaqGS:LASRElectronic

Reassessing nLIGHT (LASR) Valuation After A Sharp Share Price Move

nLIGHT (LASR) has quietly caught investor attention after a sharp move in its share price, with the stock closing at US$62.77. That shift now has many holders reassessing what the current valuation implies. See our latest analysis for nLIGHT. The recent pullback, with a 1 day share price return of negative 5.59%, comes after a strong run that includes a 30 day share price return of 18.61% and an exceptionally large 1 year total shareholder return. This suggests momentum has been building even...
CPSE:BAVA
CPSE:BAVABiotechs

Bavarian Nordic Q4 Loss Tests Confidence In Strong Trailing Earnings Narrative

Bavarian Nordic (CPSE:BAVA) has wrapped up FY 2025 with Q4 revenue of DKK 1.5b and a basic EPS loss of DKK 4.13, capping a year in which trailing twelve month revenue came in at DKK 6.2b and basic EPS at DKK 17.6. Over the past few quarters, the company has seen revenue move from DKK 1.3b in Q1 2025 to DKK 1.8b in Q3 2025 before landing at DKK 1.5b in Q4, while quarterly basic EPS ranged from DKK 2.7 in Q1 and DKK 13.7 in Q3 to a loss in Q4. With trailing net profit margin at 22% compared to...
TSX:NA
TSX:NABanks

Is It Too Late To Consider National Bank of Canada (TSX:NA) After A 63% Rally?

If you are wondering whether National Bank of Canada shares still offer value after a strong run, this article will walk through what the numbers are saying about the current price. The stock last closed at C$181.33, with returns of 4.7% over the past month and 62.8% over the past year. This may signal that expectations and perceived risk have shifted meaningfully over time. Recent headlines around Canadian banks have focused on capital strength, regulatory scrutiny and how lenders are...
ENXTPA:ALLAN
ENXTPA:ALLANBeverage

Lanson BCC H1 EPS Drop To €0.28 Challenges Bullish Growth Narratives

Lanson-BCC (ENXTPA:ALLAN) has put fresh numbers on the table, with first half FY 2025 revenue at €92.05 million and basic EPS at €0.28, alongside trailing twelve month revenue of €259.69 million and EPS of €3.31 that frame how the latest stretch compares with the recent run rate. The company has seen revenue move from €87.80 million and EPS of €0.56 in first half FY 2024 to €167.64 million and EPS of €3.03 in second half FY 2024, giving investors a clear look at how top line scale and per...
NYSE:DVA
NYSE:DVAHealthcare

A Look At DaVita (DVA) Valuation As Analyst Concerns Clash With Bullish Ratings

Why DaVita (DVA) is back in the spotlight DaVita (DVA) is back under the microscope after recent analyst reports flagged flat treatment volumes, slower expected sales growth, and pressure on free cash flow margins, even as some ratings remain very positive. See our latest analysis for DaVita. DaVita’s share price has moved to US$153.06, with a 9.9% 1 month share price return and 26.1% 3 month share price return. Its 3 year total shareholder return of 96.2% contrasts with recent concerns over...
NYSE:ECL
NYSE:ECLChemicals

Ecolab’s Global Energy Surcharge Puts Focus On Margins And Valuation

Ecolab (NYSE:ECL) has introduced a global energy surcharge for customers. The surcharge is a response to surging energy costs linked to geopolitical tensions in the Middle East. This move represents a material change in the company’s pricing approach across its international operations. Ecolab, a major provider of water, hygiene, and infection prevention solutions, is tightly exposed to input and logistics costs through its worldwide service network. Rising energy prices can influence...
SEHK:753
SEHK:753Airlines

Air China (SEHK:753) Valuation Check After Leadership Change At The Top

Air China (SEHK:753) has entered a leadership transition, with long serving President and Vice Chairman Wang Mingyuan retiring and aviation veteran Qu Guangji stepping in as President. This shift can refocus attention on board level priorities. See our latest analysis for Air China. The leadership reshuffle comes after a tough stretch for the share price, with a 30 day share price return showing a 25% decline and a year to date share price return showing a 20.68% decline, while the 1 year...
ENXTAM:BFIT
ENXTAM:BFITHospitality

Basic Fit (ENXTAM:BFIT) Earnings Surge Tests Bullish High P/E Narrative

Basic-Fit (ENXTAM:BFIT) has wrapped up FY 2025 with second half revenue of €743.2 million and basic EPS of €0.34, alongside trailing 12 month revenue of €1.42 billion and basic EPS of €0.22. These figures frame the latest numbers in a broader earnings upswing. The company has seen revenue move from €630.44 million in the second half of 2024 to €743.2 million in the second half of 2025, while basic EPS shifted from €0.06 to €0.34 over the same periods. This sets up a story where higher sales...
NYSE:VEL
NYSE:VELDiversified Financial

Velocity Financial (VEL) Net Margin Surge Tests Bearish Cash Flow Concerns

Velocity Financial FY 2025 results in focus Velocity Financial (VEL) has wrapped up FY 2025 with fourth quarter total revenue of US$57.1 million and basic EPS of US$0.89, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$84.9 million in Q4 2024 to US$57.1 million in Q4 2025, while basic EPS shifted from US$0.62 to US$0.89 over the same period, and on a trailing twelve month basis EPS stands at US$2.81 on revenue of US$183.5...
TASE:MLRN
TASE:MLRNConsumer Finance

M.L.R.N Projects And Trade TASE MLRN Net Margin Strength Reinforces Bullish Community Narratives

M.L.R.N Projects and Trade (TASE:MLRN) has wrapped up FY 2025 with fourth quarter revenue of ₪83.6 million and basic EPS of ₪0.46, capping off a twelve month stretch that delivered trailing revenue of ₪167.6 million and EPS of ₪1.90. Over the past six quarters, revenue has moved from ₪21.5 million in Q3 2024 to ₪83.6 million in Q4 2025, while quarterly EPS has ranged from ₪0.31 to ₪0.56. This sets the stage for investors to weigh those headline gains against how sustainably the business is...
SWX:VETN
SWX:VETNPackaging

Vetropack Holding (SWX:VETN) Thin 0.5% Margin Fuels Debate Around High 111x P/E

Vetropack Holding (SWX:VETN) has just posted its FY 2025 numbers, with first half revenue at CHF 412.7 million and EPS of CHF 0.49, while trailing 12 month revenue sits at CHF 792.1 million and EPS at CHF 0.19 after a period marked by a CHF 17.1 million one off loss and a 0.5% net margin in the inputs. The company has seen reported revenue move from CHF 444.9 million in the first half of 2024 to CHF 412.7 million in the first half of 2025, with EPS shifting from CHF 0.47 to CHF 0.49 over the...
NYSE:ODC
NYSE:ODCHousehold Products

Oil Dri Corporation Of America Q2 Margin Strength Reinforces Bullish EPS Stability Narrative

Oil-Dri Corporation of America (ODC) has just posted Q2 2026 results with revenue of US$117.7 million and basic EPS of US$0.87, alongside trailing twelve month EPS of US$3.62 on revenue of US$478.9 million. Over recent quarters the company has seen revenue move between US$116.9 million and US$127.9 million, while quarterly EPS has ranged from US$0.80 to US$1.13. This sets up a picture of steady top line and earnings performance that now sits on the back of 15.6% earnings growth over the past...